| Literature DB >> 30132349 |
Munjae Lee1, Kichan Yoon2, Kyu-Sung Lee1,3.
Abstract
This study analyzes the legislation process of the Korean government regarding the development of the medical device industry in the perspective of the issue network. It also aims to identify the difference in network structure between conservative and progressive governments and analyze major issues and stakeholders. It examines the network structure in the legislation process of the government to develop and support the medical device industry through social network analysis (SNA). This study conducted a policy network structure analysis of the conservative and progressive governments. SNA was used for the structure analysis, using the contents of newspaper articles as the baseline data related to the medical device industry. We analyze using the 2-mode network analysis that the node centrality is determined by eigenvector centrality. The more nodes with great power (stakeholders, information, resources) it is linked to, the greater power centrality (eigenvector centrality) it will have, which indicates that it has great influence within the network. The conservative government discussed the promotion of the medical device industry led by government departments, focusing on its potential as a future growth engine. On the contrary, the progressive government tended to have fewer stakeholders and issues around the idea, shifting the stakeholders that lead the promotion of the industry from government departments to relevant interest groups, and focusing more on policy issues like transparency than on economic issues. We identify implications to legislate the relevant act by analyzing the relevant stakeholders and issues around legislation, while reinforcing the competitiveness of Korea's medical device industry in the larger global framework. We believe that this study would comprehensively addresses the pros and cons of the government-led promotion of the medical device industry in Korea, as well as the key issues for stakeholders, which can be applicable to many other societies.Entities:
Keywords: South Korea; conservative government; legislation; medical device industry; progressive government; social network analysis (SNA)
Mesh:
Year: 2018 PMID: 30132349 PMCID: PMC6108012 DOI: 10.1177/0046958018791858
Source DB: PubMed Journal: Inquiry ISSN: 0046-9580 Impact factor: 1.730
Number of Article Searches by Time of Conservative and Progressive Governments.
| Time | Period | No. of articles | Effective no. of articles | ||
|---|---|---|---|---|---|
| Editorials | General articles | Feature articles | |||
| Conservative government | July 1, 2013 to May 29, 2016 | 25 | 9 | 9 | 43 |
| Progressive government | May 30, 2016 to May 30, 2017 | 2 | 11 | 1 | 14 |
Figure 3.Policy network in 19th assembly.
The Centrality of Stakeholder in 19th Assembly.
| No. | Stakeholder | Number of nodes | Centrality |
|---|---|---|---|
|
| Ministry of Food and Drug Safety | 13 | 0.843 |
|
| Ministry of Health and Welfare | 6 | 0.317 |
|
| Seoul National University Medical School | 4 | 0.269 |
|
| Ministry of Strategy and Finance | 2 | 0.234 |
|
| Saenuri Party member Kim | 4 | 0.157 |
|
| Ministry of Trade, Industry and Energy | 1 | 0.126 |
|
| Medical community | 3 | 0.096 |
|
| Association for Physicians for Humanism | 6 | 0.053 |
|
| Korean Medical Association | 3 | 0.041 |
|
| Korean Federation Medical Activist Groups for Health Rights | 3 | 0.039 |
|
| Korea Alliance of Patients Organization | 4 | 0.033 |
|
| Lawyers for a Democratic Society (Minbyun) | 3 | 0.029 |
|
| Institute for Democracy | 3 | 0.028 |
|
| Korean Federation Medical Activist Groups | 1 | 0.009 |
|
| People’s Solidarity for Participatory Democracy | 2 | 0.008 |
Figure 4.Policy network in 20th Assembly.
The Centrality of Chief Issues in 19th Assembly.
| No. | Chief issues | Number of nodes | Centrality |
|---|---|---|---|
|
| Agreement to develop the medical device industry | 6 | 0.496 |
|
| Stronger competitiveness for promising businesses in the future | 4 | 0.424 |
|
| Inefficiency of assessment delay | 1 | 0.239 |
|
| Conversion of some medicine into medical devices | 1 | 0.215 |
|
| Abolition of restriction on consignment of medical device manufacturing | 1 | 0.215 |
|
| Setting of the medical device distribution quality management standard | 1 | 0.215 |
|
| Implementation of the standard code for medical devices subject to tracking | 1 | 0.215 |
|
| Notification of medical device accidents to the patients | 1 | 0.215 |
|
| Partial exemption of approval for clinical trials | 1 | 0.215 |
|
| Allowance of emergency use | 1 | 0.215 |
|
| Partial declaration of the Enforcement Decree of the Medical Devices Act | 1 | 0.215 |
|
| Exclusion of heart rate monitor for exercise from medical devices | 1 | 0.215 |
|
| Revised bill for Regulations for Product Classification of Medical Device and Class by Product | 1 | 0.215 |
|
| Disagreement to develop the medical device industry | 7 | 0.080 |
|
| Simplification of health technology assessment | 1 | 0.080 |
|
| Preannouncement of legislation for the revision of the Regulation for Criteria for Providing Reimbursed Services in the National Health Insurance | 1 | 0.080 |
|
| Delay of New Health Technology Assessment | 1 | 0.080 |
|
| Revision of the Regulation for New Health Technology Assessment | 1 | 0.080 |
|
| Need for establishment of Medical-Industrial Complex | 1 | 0.068 |
|
| Need for convergence of the medical industry | 1 | 0.068 |
|
| Expansion of the sphere of activities for medical device repair businesses | 1 | 0.040 |
|
| Reduction of maximum for reexamination period of newly developed medical devices | 1 | 0.040 |
|
| Motion of partial revision of the Medical Devices Act | 1 | 0.040 |
|
| Increase in overall medical expenses | 4 | 0.036 |
|
| Possibility of the hospital’s insistent recommendation of its own medical device | 3 | 0.034 |
|
| Expectation for prevalence of the hospital’s expedients | 2 | 0.033 |
|
| Lack of penalty clauses | 1 | 0.024 |
|
| Incapacitation of the government regulation | 3 | 0.023 |
|
| Tipping effect of patients to big major hospitals | 1 | 0.020 |
|
| Bankruptcy of small clinics | 1 | 0.013 |
|
| Embezzlement of benefits in the medical device industry | 1 | 0.010 |
|
| Lack of consistency in laws | 2 | 0.009 |
|
| Risk of personal data spill | 1 | 0.008 |
|
| Difficulty in securing safety | 1 | 0.008 |
|
| Promotion of market entry by chaebol companies | 1 | 0.007 |
The Centrality of Stakeholder in 20th Assembly.
| No. | Stakeholder | Number of nodes | Centrality |
|---|---|---|---|
|
| Ministry of Health and Welfare | 7 | 0.801 |
|
| Liberty Korea Party member Kim | 3 | 0.314 |
|
| Ministry of Food and Drug Safety | 2 | 0.274 |
|
| Health Insurance Review & Assessment Service | 2 | 0.274 |
|
| Korea Medical Devices Industry Association | 3 | 0.210 |
|
| Democratic Party | 3 | 0.194 |
|
| The Minjoo Party of Korea member Oh | 2 | 0.142 |
|
| Industrial world | 3 | 0.040 |
|
| Academic world | 1 | 0.032 |
|
| Political world | 1 | 0.032 |
|
| National Assembly | 2 | 0.026 |
|
| Candidates for presidential election | 1 | 0.000 |
The Centrality of Chief Issues in 20th Assembly.
| No. | Chief issues | Number of nodes | Centrality |
|---|---|---|---|
|
| Agreement to develop the medical device industry | 4 | 0.485 |
|
| Disclosure of price information for medical devices | 3 | 0.430 |
|
| Establishment of a distribution data system for medical devices | 3 | 0.430 |
|
| Establishment of an integrated data management system for medical devices | 3 | 0.401 |
|
| Reinforcement of competitiveness for SMEs | 1 | 0.255 |
|
| Need for introduction of a remote medical system | 1 | 0.255 |
|
| Reinforcement of medical license management | 1 | 0.255 |
|
| Priority in passing related laws | 4 | 0.100 |
|
| Inclusion of identification code on medical devices | 1 | 0.100 |
|
| Reinforcement of punishment for objects of rebate | 2 | 0.075 |
|
| Potential for development into health care privatization | 1 | 0.061 |
|
| Disagreement to develop the medical device industry | 1 | 0.061 |
|
| Report of supply details of medical devices | 1 | 0.045 |
|
| Need for guaranteed price maintenance of medical devices | 1 | 0.012 |
|
| Opposition to disclosure of price information | 1 | 0.012 |
|
| Passing of the amendment bill of the Medical Devices Act | 1 | 0.008 |
|
| Importance of quaternary industry | 1 | 0.00 |
SMEs: Small and medium-sized enterprises.
Kingdon and Muccinaroni Analysis.
| Type | Analysis variable | Conservative government | Progressive government | |
|---|---|---|---|---|
| Kingdon MSF | Problem stream | Index clarity | ○ | × |
| Focus event | × | × | ||
| Public opinion formation | × | × | ||
| Feedback | × | × | ||
| Politics stream | Change in national atmosphere | ○ | ○ | |
| Change in participant | ○ | ○ | ||
| Change in argument | ○ | ○ | ||
| Policy stream | Alternative | × | ○ | |
| Policy process | × | × | ||
| Policy window | Open | × | × | |
| Closed | ○ | Δ | ||
| Mucciaroni ICF | Fortunes Declined | ? | ||
Note. MSF = Multiple Streams Framework; ICF = Interest Group Standing Change Framework. ○ = supported; available; × = unsupported; unavailable; Δ = partially OK (between ○ and ×); ? = possible future.
A comparison of the Medical Device Industry Development and Support Act in Conservative and Progressive Governments.
| Category | Tabled on | Tabled by | Purpose | Details |
|---|---|---|---|---|
| Conservative government | May 24, 2013 | 10 MPs including Jese Oh | • To select it as a future growth engine industry | • Establish a comprehensive plan to promote the medical device industry |
| Progressive government | July 22, 2016 | 16 MPs including Gisun Kim | • To develop biotechnology and information technology | • Establish a comprehensive plan for developing advanced medical devices |
Note. The conservative government defined the medical device industry as a future growth engine industry and proposed a market-friendly act that includes planning, promotion, support, and exportation of the products of the medical device industry. In contrast, the progressive government set about improving the competitiveness of the medical device industry and national health promotion as their major goals and focused on government regulation, such as certification of the medical device industry and terms for confidentiality. It also limited market intervention through granting a temporary approval for special cases.